Related Experiment Videos
Periodontal therapy: a novel acute inflammatory model
F D'Aiuto1, M Parkar, M S Tonetti
1Periodontology Unit, Eastman Dental Institute and Hospital, University College London, 256 Gray's Inn Road, London WC1X 8LD, UK. f.daiuto@eastman.ucl.ac.uk
Summary
Intensive periodontal therapy in severe periodontitis patients triggers a moderate, short-term inflammatory response. This study proposes this therapy as a reliable, non-drug-induced in vivo model for acute inflammation research.
Area of Science:
- Oral Medicine
- Immunology
- Periodontology
Background:
- Severe periodontitis is a complex oral inflammatory disease.
- Understanding the inflammatory response to treatment is crucial for patient outcomes.
- Developing reliable in vivo models for inflammation is essential for research.
Purpose of the Study:
- To develop a novel in vivo model of acute inflammation.
- To investigate the inflammatory response following intensive periodontal therapy.
- To assess the utility of periodontal therapy as a non-drug-induced inflammation model.
Main Methods:
- A clinical trial was conducted with 55 severe periodontitis patients.
- Participants underwent intensive periodontal therapy.
- Blood samples were analyzed for biomarkers (TNF-alpha, IL-6, CRP, Fibrinogen) and differential blood counts at multiple time points.
Main Results:
- Tumor Necrosis Factor-alpha (TNF-alpha) levels increased at 1 day post-therapy.
- Interleukin-6 (IL-6), C-reactive protein (CRP), and Fibrinogen peaked 24 hours post-therapy, returning to baseline within 30 days.
- Mild neutrophilia, monocytosis, and lymphopenia were observed.
Conclusions:
- Intensive periodontal therapy elicits a moderate inflammatory response lasting approximately one week.
- This therapeutic approach serves as a novel and dependable in vivo model for acute inflammation.
- The model is non-drug-induced, offering a unique research avenue.